ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

Focalin

HCID 154100
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
19262-68-1
標準SMILES
COC(=O)[C@H](c1ccccc1)[C@H]1CCCCN1.Cl
InChIKey
JUMYIBMBTDDLNG-OJERSXHUSA-N
分子式
C14H20ClNO2
平均分子量
269.77 g/mol
単同位体質量
269.1182566

概要

Dexmethylphenidate Hydrochloride is a synthetic sympathomimetic amine with CNS stimulating properties. Dexmethylphenidate hydrochloride acts by facilitating the release of catecholamines, particularly noradrenaline and dopamine, from nerve terminals in the brain and inhibits their uptake. This leads to an increase in motor activity, causes euphoria, mental alertness and excitement and suppresses appetite. This drug causes dependence and may cause an increase in heart rate and blood pressure. It is used in the treatment of attention deficit hyperactivity disorder. It may also be used in the treatment of fatigue and other nervous system effects seen with chemotherapy.

名称と識別子

優先名称
Focalin
IUPAC
methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate;hydrochloride

名称と別名

Dexmethylphenidate hydrochlorideFocalinD-threo-Methylphenidate hydrochloride19262-68-1dex-methylphenidate hydrochloride1678OK0E08Methylphenidate d-threo-form hydrochloride2-Piperidineacetic acid, alpha-phenyl-, methyl ester, hydrochloride, (alphaR,2R)-AZSTARYS COMPONENT DEXMETHYLPHENIDATE HYDROCHLORIDEFocalinxrXR, FocalinRefChem:56470
名称をさらに表示
Hydrochloride, DexmethylphenidateDexmethylphenidate Hydrochloride Extended-releaseDexmethylphenidate HCl23655-65-4Focalin XRDexmethylphenidate hydrochloride [USAN]methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate;hydrochloriderac-threo-Methylphenidate Hydrochloride

データベース識別子

CAS
19262-68-1、23655-65-4
PubChem CID
154100
DTXSID
DTXSID50940927
ChEMBL
CHEMBL904
UNII
1678OK0E08、4B3SC438HI
EC Number
111-173-8

物性

構造計算による物性

極性表面積
38.3 Ų
水素結合供与体数
2
水素結合受容体数
3
回転可能結合数
4
重原子数
18
形式電荷
0
複雑度
249

実験および物理化学的性質

Human Drugs · 3 件

Breast Feeding; Lactation; Milk, Human; Adrenergic Agents; Central Nervous System Stimulants; Dopamine Agents; Sympathomimetics; Wakefulness-Promoting Agents

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

危険有害性情報

Hazard Classes and CategoriesAcute Tox. 4 (100%)

毒性情報

Exposure Routes11-52%
Toxicity Summary · 1 件

Methylphenidate blocks dopamine uptake in central adrenergic neurons by blocking dopamine transport or carrier proteins. Methylphenidate acts at the brain stem arousal system and the cerebral cortex and causes increased sympathomimetic activity in the central nervous system. Methylphenidate is a catecholamine reuptake inhibitor that indirectly increases catecholaminergic neurotransmission by inhibiting the dopamine transporter (DAT) and norepinephrine transporter (NET), which are responsible for clearing catecholamines from the synapse, particularly in the striatum and meso-limbic system.

Signs and Symptoms · 1 件

Symptoms of overdose include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes.

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury

化学と産業

薬理情報

Metabolism/Metabolitesepatic, methylphenidate is metabolized primarily by de-esterification to ritalinic acid (α-phenyl-2-piperidine acetic acid, PPAA), which has little to no pharmacologic activity. Route of Elimination: Renal Half Life: 2-4 hours
FDA Pharmacological Classification · 2 件

DEXMETHYLPHENIDATE HYDROCHLORIDE

Central Nervous System Stimulation [PE]; Central Nervous System Stimulant [EPC]

MeSH Pharmacological Classification · 2 件

A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.

Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake.

用途と製造

UsesDexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment.

関連反応

2 件
反応記録を作成
HRID 589544 の反応式
HRID 589544生成物として
HRID 599389 の反応式
HRID 599389生成物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
· 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Dexmethylphenidate hydrochloride

vLess-DILI-concern

7

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Toxicity DataOral, Mouse: LD<sub>50</sub>=190mg/kg